Martha G. Sensel

Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy

James B. Nachman, Harland N. Sather, Martha G. Sensel et al. · New England Journal of Medicine · 1998 · 449 citations · Full text

Medicine, Oncology, Pediatrics +17

Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group

Jorge A. Ortega, Edwin C. Douglass, James H. Feusner et al. · Journal of Clinical Oncology · 2000 · 342 citations

Medicine, Oncology, Pediatrics +13

Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.

Nyla A. Heerema, James B. Nachman, Harland N. Sather et al. · PubMed · 1999 · 211 citations

Life Sciences, Genetics, Oncology +14

Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia

Lei Sun, Nyla A. Heerema, Lisa Crotty et al. · Proceedings of the National Academy of Sciences · 1999 · 197 citations

Life Sciences, Genetics, Molecular Biology +13

Hepatocellular Carcinoma in Children and Adolescents: Results From the Pediatric Oncology Group and the Children’s Cancer Group Intergroup Study

Howard M. Katzenstein, Mark Krailo, Marcio H. Malogolowkin et al. · Journal of Clinical Oncology · 2002 · 186 citations

Medicine, Oncology, Pediatrics +17